Clinical Trials Browser

Lethal Congenital Contracture Syndrome 2 × pembrolizumab × Thoracic × Clear all

NCT07111520 2025-10-22

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 1/2 Recruiting

Lethal Congenital Contracture Syndrome 2, Carcinoma, Non-Small-Cell Lung